Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Thompson

Showing results (31-40 of 200) with videos related to

Pageof 20
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 2, 2021
Paradigm shifts: Early initiation of high-efficacy disease-modifying treatment in multiple sclerosisHans-Peter Hartung, Sven G Meuth, Alan J Thompson
The Lancet. Neurology|May 21, 2018
Applying the 2017 McDonald diagnostic criteria for multiple sclerosis - Authors' replyAlan J Thompson, Stephen C Reingold, Jeffrey A Cohen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 15, 2010
Effect sizes can be misleading: is it time to change the way we measure change?Jeremy C Hobart, Stefan J Cano, Alan J Thompson
The Lancet. Neurology|May 13, 2026
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis - Authors' replyXavier Montalban, Jiwon Oh, Timothy Coetzee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
The measure tells the tale: Clinical outcome measures in multiple sclerosisHanneke E Hulst, Alan J Thompson, Jeroen Jg Geurts
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2004
Overview of London trial of intramuscular interferon-beta Ia in primary-progressive multiple sclerosisDavid H Miller, Siobhan M Leary, Alan J Thompson
The Lancet. Neurology|July 10, 2003
The therapeutic potential of cannabisDavid Baker, Gareth Pryce, Gavin Giovannoni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 26, 2019
MSJ 2019 - Editorial commentAlan J Thompson, Jack Antel, William Bill Carroll, et al.
Clinical Medicine (London, England)|May 14, 2004
Integrated care pathways: disease-specific or process-specific?Simon G M Edwards, Alan J Thompson, E Diane Playford
Neurorehabilitation and Neural Repair|July 2, 2004
Rehabilitation of the cancer patient: experience in a neurological unitPeter Garrard, Chris Farnham, Alan J Thompson, et al.
Pageof 20

Showing results (31-40 of 200) with videos related to

Sort By:
Pageof 20
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 2, 2021
Paradigm shifts: Early initiation of high-efficacy disease-modifying treatment in multiple sclerosisHans-Peter Hartung, Sven G Meuth, Alan J Thompson
The Lancet. Neurology|May 21, 2018
Applying the 2017 McDonald diagnostic criteria for multiple sclerosis - Authors' replyAlan J Thompson, Stephen C Reingold, Jeffrey A Cohen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 15, 2010
Effect sizes can be misleading: is it time to change the way we measure change?Jeremy C Hobart, Stefan J Cano, Alan J Thompson
The Lancet. Neurology|May 13, 2026
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis - Authors' replyXavier Montalban, Jiwon Oh, Timothy Coetzee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
The measure tells the tale: Clinical outcome measures in multiple sclerosisHanneke E Hulst, Alan J Thompson, Jeroen Jg Geurts
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2004
Overview of London trial of intramuscular interferon-beta Ia in primary-progressive multiple sclerosisDavid H Miller, Siobhan M Leary, Alan J Thompson
The Lancet. Neurology|July 10, 2003
The therapeutic potential of cannabisDavid Baker, Gareth Pryce, Gavin Giovannoni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 26, 2019
MSJ 2019 - Editorial commentAlan J Thompson, Jack Antel, William Bill Carroll, et al.
Clinical Medicine (London, England)|May 14, 2004
Integrated care pathways: disease-specific or process-specific?Simon G M Edwards, Alan J Thompson, E Diane Playford
Neurorehabilitation and Neural Repair|July 2, 2004
Rehabilitation of the cancer patient: experience in a neurological unitPeter Garrard, Chris Farnham, Alan J Thompson, et al.
Pageof 20